Investors Overview

Company Profile

Valeo Pharma Inc. is a specialty pharmaceutical company focused on acquiring, in-licensing and commercializing innovative pharmaceutical products with a primary focus on neurodegenerative diseases, Oncology and supportive care as well as hospital products. Valeo's shares trade on the CSE ("VPH")

Stock Exchange: CSE
Stock Ticker: VPH

Head Office
16667, Hymus Boul.
Kirkland, Qc
H9H 4R9

Investor Relation contact
Frederic Dumais
Director Communications and Investor Relations
dumais@valeopharma.com